A detailed history of Vontobel Holding Ltd. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Vontobel Holding Ltd. holds 24,400 shares of SRPT stock, worth $3.86 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
24,400
Previous 25,278 3.47%
Holding current value
$3.86 Million
Previous $2.44 Million 29.59%
% of portfolio
0.03%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$93.7 - $141.53 $82,268 - $124,263
-878 Reduced 3.47%
24,400 $3.16 Million
Q4 2023

Jun 03, 2024

BUY
$67.31 - $124.76 $192,708 - $357,187
2,863 Added 12.77%
25,278 $2.44 Million
Q4 2023

Jan 29, 2024

BUY
$67.31 - $124.76 $192,708 - $357,187
2,863 Added 12.77%
25,278 $2.44 Million
Q3 2023

Jun 03, 2024

SELL
$102.5 - $123.59 $81,795 - $98,624
-798 Reduced 3.44%
22,415 $2.72 Million
Q3 2023

Oct 10, 2023

SELL
$102.5 - $123.59 $81,795 - $98,624
-798 Reduced 3.44%
22,415 $2.72 Million
Q2 2023

Jun 03, 2024

SELL
$106.4 - $157.19 $414,747 - $612,726
-3,898 Reduced 14.38%
23,213 $2.66 Million
Q2 2023

Jul 24, 2023

SELL
$106.4 - $157.19 $414,747 - $612,726
-3,898 Reduced 14.38%
23,213 $2.66 Million
Q1 2023

Jun 03, 2024

BUY
$117.53 - $155.99 $318,623 - $422,888
2,711 Added 11.11%
27,111 $3.74 Million
Q1 2023

Apr 12, 2023

SELL
$117.53 - $155.99 $182,759 - $242,564
-1,555 Reduced 5.42%
27,111 $3.74 Million
Q4 2022

Feb 14, 2023

BUY
$100.86 - $132.13 $796,693 - $1.04 Million
7,899 Added 38.04%
28,666 $3.71 Million
Q3 2022

Nov 04, 2022

BUY
$75.71 - $119.24 $124,012 - $195,315
1,638 Added 8.56%
20,767 $2.3 Million
Q2 2022

Jul 27, 2022

SELL
$62.69 - $88.44 $15,672 - $22,110
-250 Reduced 1.29%
19,129 $1.47 Million
Q1 2022

May 13, 2022

SELL
$63.15 - $90.42 $73,001 - $104,525
-1,156 Reduced 5.63%
19,379 $1.51 Million
Q4 2021

Feb 14, 2022

BUY
$77.28 - $99.42 $244,591 - $314,664
3,165 Added 18.22%
20,535 $1.85 Million
Q3 2021

Oct 29, 2021

BUY
$65.97 - $92.48 $70,192 - $98,398
1,064 Added 6.53%
17,370 $1.61 Million
Q2 2021

Aug 06, 2021

BUY
$69.38 - $86.75 $278,005 - $347,607
4,007 Added 32.58%
16,306 $1.27 Million
Q1 2021

May 11, 2021

SELL
$72.25 - $168.95 $11,849 - $27,707
-164 Reduced 1.32%
12,299 $917,000
Q4 2020

Feb 12, 2021

BUY
$125.56 - $178.74 $1.56 Million - $2.23 Million
12,463 New
12,463 $1.19 Million

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $13.8B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Vontobel Holding Ltd. Portfolio

Follow Vontobel Holding Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Holding Ltd. with notifications on news.